Mckesson (MCK) Asset Writedowns and Impairment (2010 - 2026)
Mckesson (MCK) reported Asset Writedowns and Impairment of -$81.0 million for Q1 2026, down 133.47% year-over-year from $242.0 million in Q1 2025, and down 200.0% quarter-over-quarter from $81.0 million in Q4 2025.
Mckesson (MCK) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Mckesson (MCK) has 12 years of Asset Writedowns and Impairment data on file, last reported at -$81.0 million in Q1 2026.
- Asset Writedowns and Impairment for Q1 2026 came in at -$81.0 million, down 133.47% year-over-year; the trailing twelve-month figure through Dec 2025 was $323.0 million (down 53.72% YoY), and the FY2025 annual result was $98.0 million, up 127.91% from the prior year.
- Asset Writedowns and Impairment declined to -$81.0 million in Q1 2026 per MCK's latest filing, from $81.0 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $643.0 million in Q3 2024 and troughed at -$166.0 million in Q3 2022.
- A 5-year average of $80.6 million and a median of $15.0 million in 2024 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment plunged 148.54% in 2022, then surged 1761.29% in 2023.
- A 5-year view of Asset Writedowns and Impairment shows it stood at -$31.0 million in 2022, then surged by 1761.29% to $515.0 million in 2023, then plunged by 95.15% to $25.0 million in 2024, then jumped by 224.0% to $81.0 million in 2025, then sank by 200.0% to -$81.0 million in 2026.
- Business Quant data shows MCK's Asset Writedowns and Impairment at -$81.0 million in Q1 2026, $81.0 million in Q4 2025, and -$2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -81.00 Mn |
| Mar 31, 2026 | -81.00 Mn |
| Dec 31, 2025 | 81.00 Mn |
| Dec 31, 2025 | 81.00 Mn |
| Sep 30, 2025 | -2.00 Mn |
| Sep 30, 2025 | -2.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 242.00 Mn |
| Mar 31, 2025 | 242.00 Mn |
| Dec 31, 2024 | 25.00 Mn |
| Dec 31, 2024 | 25.00 Mn |
| Sep 30, 2024 | 643.00 Mn |
| Sep 30, 2024 | 643.00 Mn |
| Jun 30, 2024 | 15.00 Mn |
| Jun 30, 2024 | 15.00 Mn |
| Mar 31, 2024 | 15.00 Mn |
| Mar 31, 2024 | 15.00 Mn |
| Dec 31, 2023 | 515.00 Mn |
| Dec 31, 2023 | 515.00 Mn |